{"log_id": 8515875080886789391, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 2e-06, "average": 0.999257, "min": 0.995152}, "location": {"width": 150, "top": 238, "height": 22, "left": 221}, "words": "因为不良事件停药"}, {"probability": {"variance": 7e-06, "average": 0.997379, "min": 0.994822}, "location": {"width": 21, "top": 238, "height": 20, "left": 531}, "words": "6%"}, {"probability": {"variance": 0, "average": 0.999485, "min": 0.999485}, "location": {"width": 19, "top": 239, "height": 18, "left": 668}, "words": "6"}, {"probability": {"variance": 1e-06, "average": 0.998802, "min": 0.997673}, "location": {"width": 20, "top": 238, "height": 19, "left": 958}, "words": "3%"}, {"probability": {"variance": 9e-06, "average": 0.997688, "min": 0.990728}, "location": {"width": 147, "top": 275, "height": 24, "left": 222}, "words": "由于其他原因中断"}, {"probability": {"variance": 0, "average": 0.999343, "min": 0.998714}, "location": {"width": 23, "top": 273, "height": 21, "left": 670}, "words": "7%"}, {"probability": {"variance": 5e-06, "average": 0.99774, "min": 0.995596}, "location": {"width": 32, "top": 275, "height": 20, "left": 951}, "words": "5%"}, {"probability": {"variance": 0, "average": 0.9869, "min": 0.9869}, "location": {"width": 28, "top": 228, "height": 100, "left": 1136}, "words": "明"}, {"probability": {"variance": 0.003963, "average": 0.974758, "min": 0.668374}, "location": {"width": 602, "top": 311, "height": 23, "left": 241}, "words": "在48周和144周期间受试者确认的HIV-1RNA达到并维持在<400拷贝/mL的水平"}, {"probability": {"variance": 0.000379, "average": 0.994615, "min": 0.880127}, "location": {"width": 544, "top": 342, "height": 21, "left": 242}, "words": "包括在48周和144周期间确认的病毒反弹和不能达到<400拷贝/mL的水平"}, {"probability": {"variance": 0.000182, "average": 0.993907, "min": 0.942281}, "location": {"width": 482, "top": 370, "height": 21, "left": 240}, "words": "包括失访、受试者中途退出、依从性不良、违反方案以及其他原因"}, {"probability": {"variance": 0.005691, "average": 0.978501, "min": 0.49859}, "location": {"width": 808, "top": 450, "height": 27, "left": 206}, "words": "在基线根据HIV-1RNA浓度(>或≤100,00拷贝/mL)和CD4细胞计数(<或≥200"}, {"probability": {"variance": 0.002481, "average": 0.984444, "min": 0.727295}, "location": {"width": 795, "top": 477, "height": 30, "left": 207}, "words": "个细胞/mm3)对患者进行分层,在第144周经分层的两个治疗组人群达到血HIV-1"}, {"probability": {"variance": 0.000361, "average": 0.992773, "min": 0.885489}, "location": {"width": 819, "top": 508, "height": 27, "left": 207}, "words": "RNA<400拷贝/毫升的情况相似。经过144周的治疗,在富马酸替诺福韦二吡呋酯和"}, {"probability": {"variance": 0.004688, "average": 0.982902, "min": 0.664558}, "location": {"width": 807, "top": 538, "height": 27, "left": 208}, "words": "司他夫定治疗组,分别有62%和58%的受试者的HIV-1RNA确认达到并保持在<50"}, {"probability": {"variance": 9.7e-05, "average": 0.997008, "min": 0.93726}, "location": {"width": 818, "top": 567, "height": 26, "left": 205}, "words": "拷贝/mL。在富马酸替诺福韦二吡呋酯组CD4细胞计数相对于基线值增加的平均值为"}, {"probability": {"variance": 0.00258, "average": 0.986682, "min": 0.729177}, "location": {"width": 474, "top": 597, "height": 25, "left": 214}, "words": "63个细胞/mm3,而司他夫定组为283个细胞/mm3"}, {"probability": {"variance": 2e-05, "average": 0.997164, "min": 0.97671}, "location": {"width": 826, "top": 646, "height": 28, "left": 206}, "words": "经过144周治疗,富马酸替诺福韦二吡呋酯组有11名受试者、司他夫定组有9名受试"}, {"probability": {"variance": 0.002783, "average": 0.969929, "min": 0.829262}, "location": {"width": 296, "top": 674, "height": 28, "left": 206}, "words": "者出现新的CDCC类不良事件"}, {"probability": {"variance": 0.00435, "average": 0.982612, "min": 0.588241}, "location": {"width": 828, "top": 726, "height": 27, "left": 206}, "words": "研究934:富马酸替诺福韦二吡呋酯+恩曲他滨+依非韦伦齐多夫定/拉米夫定+依非韦"}, {"probability": {"variance": 1e-06, "average": 0.998612, "min": 0.997115}, "location": {"width": 69, "top": 757, "height": 24, "left": 207}, "words": "伦比较"}, {"probability": {"variance": 0.006666, "average": 0.979764, "min": 0.564922}, "location": {"width": 822, "top": 784, "height": 28, "left": 207}, "words": "研究934是一项随机、开放标签、活性药物对照的多中心试验,在511例-未接受过抗"}, {"probability": {"variance": 9.8e-05, "average": 0.996969, "min": 0.938107}, "location": {"width": 829, "top": 814, "height": 26, "left": 207}, "words": "逆转录病毒治疗的受试者中,对恩曲他滨+富马酸替诺福韦二吡呋酯与依非韦伦合用"}, {"probability": {"variance": 0.002425, "average": 0.989309, "min": 0.686976}, "location": {"width": 821, "top": 840, "height": 29, "left": 210}, "words": "与齐多夫定/拉米夫定固定剂量复方制剂与依非韦伦合用进行比较,报告了144周期间"}, {"probability": {"variance": 2.1e-05, "average": 0.997401, "min": 0.974469}, "location": {"width": 825, "top": 868, "height": 29, "left": 206}, "words": "的数据。试验第96周至第144周期间,受试者接受恩曲他滨和富马酸替诺福韦二吡呋"}, {"probability": {"variance": 1.5e-05, "average": 0.998173, "min": 0.978871}, "location": {"width": 831, "top": 899, "height": 27, "left": 205}, "words": "酯固定剂量复方制剂与依非韦伦联合治疗代替恩曲他滨+富马酸替诺福韦二吡呋酯与"}, {"probability": {"variance": 4e-06, "average": 0.999022, "min": 0.98842}, "location": {"width": 826, "top": 926, "height": 27, "left": 207}, "words": "依非韦伦联合治疗。受试者平均年龄为38岁(范围为18~80),86%为男性,59%为"}, {"probability": {"variance": 0.000168, "average": 0.994324, "min": 0.941504}, "location": {"width": 814, "top": 957, "height": 26, "left": 210}, "words": "白人,23%为黑人。基线CD4细胞计数平均值为245个细胞/mm3(范围为2-1191)"}, {"probability": {"variance": 0.007411, "average": 0.966872, "min": 0.549497}, "location": {"width": 799, "top": 986, "height": 29, "left": 208}, "words": "基线血浆HIV1RNA中位值是5.01log10拷贝/mL(范围为3.56~6.54)。根据基线"}, {"probability": {"variance": 0.007176, "average": 0.976222, "min": 0.462}, "location": {"width": 815, "top": 1015, "height": 27, "left": 214}, "words": "CD4*细胞计数(<或≥200个细胞/mm3)对受试者进行分层;41%受试者CD4+细胞计"}, {"probability": {"variance": 0.003492, "average": 0.980262, "min": 0.706161}, "location": {"width": 812, "top": 1044, "height": 27, "left": 207}, "words": "数<200个细胞/mm3,51%受试者者基线病毒载量>100,000拷贝/mL。基线无依非韦"}, {"probability": {"variance": 2e-06, "average": 0.998748, "min": 0.994522}, "location": {"width": 501, "top": 1073, "height": 26, "left": 207}, "words": "伦耐药受试者在48周和144周时的治疗结果见表10"}, {"probability": {"variance": 0.038491, "average": 0.804333, "min": 0.580751}, "location": {"width": 164, "top": 1134, "height": 133, "left": 902}, "words": "业务月章"}, {"probability": {"variance": 0.000551, "average": 0.957848, "min": 0.934374}, "location": {"width": 34, "top": 1525, "height": 20, "left": 1005}, "words": "20"}], "language": 3}